Skip to main content
Premium Trial:

Request an Annual Quote

Bayer, Foundation Medicine Partner on NGS-Based Companion Diagnostic Test Development

NEW YORK (GenomeWeb) – Bayer and Foundation Medicine said today that they have entered a global collaboration to develop next-generation sequencing companion diagnostics, beginning with a test to identify patients eligible for treatment with larotrectinib (Vitrakvi), a TRK inhibitor now approved in the US for patients with NTRK fusions regardless of tumor type or location.

According to the partners, the agreement further allows for collaboration across multiple other oncology drug candidates and approved therapies developed by Bayer. It also covers Cambridge, Massachusetts-based Foundation's full test portfolio, including FoundationOne CDx, which has been approved by the US Food and Drug Administration for pan-cancer solid tumor CDx applications.

"We are excited to collaborate with Foundation Medicine to develop new companion diagnostics and provide tools to move to a more personalized treatment approach," Robert LaCaze, head of Germany-based Bayer's oncology strategic business unit, said in a statement. "The development of a companion diagnostic for Vitrakvi, and our broader collaboration with Foundation Medicine, is an important step forward toward expanding access to testing and identifying the right treatment options for patients with cancer."

Financial terms of the agreement were not disclosed.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.